SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-033158
Filing Date
2018-06-07
Accepted
2018-06-07 08:00:43
Documents
4
Period of Report
2018-06-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tv496065_8k.htm 8-K 20696
2 EXHIBIT 4.1 tv496065_ex4-1.htm EX-4.1 95312
3 EXHIBIT 10.1 tv496065_ex10-1.htm EX-10.1 49761
4 EXHIBIT 10.2 tv496065_ex10-2.htm EX-10.2 19536
  Complete submission text file 0001144204-18-033158.txt   186802
Mailing Address 1745 BROADWAY, 17TH FLOOR NEW YORK NY 10019
Business Address 1745 BROADWAY, 17TH FLOOR NEW YORK NY 10019 201-488-0460
BRAINSTORM CELL THERAPEUTICS INC. (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 207273918 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36641 | Film No.: 18885231
SIC: 2836 Biological Products, (No Diagnostic Substances)